Advanced Non-small Cell Lung Cancer, HER2 Mutation trials recruiting in New York

Fewer than 3 recruiting trials found.

All Advanced Non-small Cell Lung Cancer, HER2 Mutation trials nationally

Cities in New York

Recruiting trials in New York

• A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
  NCT06452277 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: New Hyde Park